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THE ROLE OF FREQUENT ENGAGEMENT IN ALLIANCES IN FIRM LIKELIHOOD TO PATENT: FIRST WAVE 




This article explores the role of alliance experience in firm innovation; it argues that, while cumulative 
alliance experience has a marginally diminishing contribution to likelihood of firm innovation over 
time, frequent engagement in alliances and an expanding alliance portfolio inhabit an enhancing role.  
This reveals new dimensions to the role of alliance experience as an antecedent to firm learning in 
managing alliances and to the development of alliance capabilities. 
 
Design/methodology/approach 
The paper estimates a range of models identifying the relationship between alliance experience and 
firm innovation. The panel data sample captures the full range of firms active in the UK bio-
pharmaceuticals sector during the early stages of its development, observing them from 1991 to 2001.  
An exploratory case study analysis is employed to shed light on the nuanced factors linking frequent 
engagement in alliances to the development of practices for efficient alliance management.   
 
Findings 
The paper shows that cumulative alliance experience has a marginally diminishing contribution to 
likelihood of firm innovation over time, while frequent engagement in alliances and the ensuing 
expansion of alliance portfolios, enhance firm innovation.  The exploratory case analysis demonstrates 
a link between frequent engagement in alliances and the development of processes for alliance 
management that could collectively reflect alliance capabilities.   
 
Originality/value 
Our contribution derives from a longitudinal analysis of an original panel dataset that maps the UK 
bio-pharmaceuticals sector over the initial period of its development.  The paper (a) sheds light on 
factors that can impel firms to form alliance capabilities, and (b) extends a currently thin body of work 
on the foundations and antecedents to alliance and alliance portfolio capabilities. 
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1. Introduction 
As the popularity of strategic alliances is increasing and such alliances are becoming an 
integral component in business development, attention in the research community has moved 
towards an exploration of their role in firm performance and innovation.  Formal and informal 
interactions with external actors have long being argued to play a fundamental role in firm innovation 
(von Hippel, 1988, Frankort et al., 2012, Rice et al., 2012, Colombo et al., 2011, Demirkan, 2018).  
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However, it is accepted that alliances carry coordination costs and risks of misappropriation, and these 
frequently diminish chances of success or preclude full acquisition of anticipated benefits (e.g. de Man 
and Duysters, 2005, Gkypali et al., 2017, Faems et al., 2010).  A substantial body of literature finds a 
positive relationship between the extent of alliances and firm innovation performance, whilst other 
work identifies diminishing and even negative returns (Hoang and Rothaermel, 2005, Sampson, 2005, 
Laursen and Salter, 2006, Rothaermel and Deeds, 2006).  As a result, a growing strand in the literature 
has examined the factors enabling firms to generate and capture value from alliances.  One such factor 
is alliance experience accumulation: as firms develop greater experience in managing alliances they 
become better at coordinating cross-organisational tasks and knowledge flows (e.g. Sampson, 2005).  
Another factor that can improve performance in alliances, is developing formal and codified processes 
and routines for alliance management (for example, the establishment of dedicated alliance 
functions), which are argued to capture, or to be reflective of, firm-specific alliance management 
capabilities (Kale et al., 2002, Kale and Singh, 2009, 2007, Heimericks and Duysters, 2007, Sampson, 
2005, Schreiner et al., 2009, Di Guardo and Harrigan, 2016, Shukla and Mital, 2018).  Whilst these 
contributions offer useful insights, much the greater part of current theorising has been constructed 
via the use of cross-sectional data.  Longitudinal explorations are scarce, thus we lack a nuanced 
understanding of the type of changes that occur within firms over time with respect to enhanced 
innovation potential from engaging in alliances.  
The contribution of this paper is that, on the basis of a longitudinal approach, it examines how 
frequent engagement in alliances and expanding alliance portfolios (a compilation of 
contemporaneous alliances) impact on the likelihood of firm innovation; this offers a longitudinal 
approach that is lacking in the current literature (Draulans et al., 2003; Rothaermel and Deeds, 2006) 
with few notable exceptions (Di Guardo and Harrigan, 2016, Belderbos et al., 2015).  A dynamic 
approach is appealing as it captures the impact on innovation of firm learning with respect to 
management of alliances.  Such learning is evident in the use of past alliance experience to support 
conflict avoidance or management, and the effective coordination of knowledge sharing and 
communication with partners.  Improved management can affect value capture in alliances especially 
as firms manage expanding alliance portfolios due to both potential of cross-partner asymmetries and 
knowledge redundancies, which are common in the bio-pharmaceuticals sector (Diestre and 
Rajagopalan, 2012, Caner and Tyler, 2013).  The paper uses longitudinal econometric panel data 
analysis to explore its hypotheses.  Secondary to this, we deploy a case analysis to capture the nuanced 
changes due to learning, shedding more light on the role of frequent engagement in alliances in 
compelling firms to direct their attention and resources in developing practices and routines for 
alliance management.  This unpacks the antecedents to alliance capabilities and travels beyond 
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current understandings in relation to experience accumulation.  As highlighted in a recent review 
(Wang and Rajagopalan, 2015), research on the antecedents to alliance and alliance portfolio 
capabilities is rather thin.  This paper contributes to exploring this link further.  
Our arguments are explored in the context of a unique, bespoke and specially assembled 
dataset, comprising the population of firms in the UK bio-pharmaceutical sector (110 firms ‘alive’ in 
2003) and active during the period 1991 to 2001.  The UK bio-pharmaceutical sector presents an ideal 
setting for investigation. The UK accounts for a significant share of the worldwide bio-pharmaceutical 
sector (McKinsey, 2014) and enjoys a revealed technological advantage (OECD, 2017) and comparative 
advantage (OECD, 2008) in this high-tech sector.  Moreover, the UK is a prime example of the Liberal 
Market Economy variant detailed in the Varieties of Capitalism literature (Hall and Soskice, 2001, 
Hancke, 2009), where the socio-economic institutional configuration is associated with international 
competitiveness of industries that are characterised by radical innovations (such as the pharma and 
biotech industries).  
The period 1991 and 2001 is perceived to be particularly apposite for our analysis as it exhibits 
several critical features: (a) a first instance and general upsurge in alliances (not only in the UK bio-
pharmaceutical sector, but also in other sectors and territories (Kang and Sakai, 2000)); (b) the 
emergence of alliances as an integral component in firm R&D strategies in the bio-pharmaceutical 
industry (Hagedoorn, 2002, Demirkan, 2018, Powell et al., 2005) but also more generally (Rice et al., 
2012); and, (c) the presence of significant variation - visible in terms of identifiable peaks and troughs 
in alliance activity - especially towards the end of the period (Hagedoorn, 2002).  Moreover, this marks 
a paradigmatic era of new technology evolution, with new entrants and established firms developing 
capabilities in biotechnologies through alliance activity (Hopkins et al., 2007): thus it provides a 
historical backdrop that aids understanding of development of similar technologies, for example, 
nanotechnologies (Rothaermel and Thursby, 2007).    
The remainder of this paper is structured as follows.  Section 2 sets-out the theoretical 
background to the study and reviews the literature on alliance experience and alliance/alliance 
portfolio capabilities.  Sections 3 and 4 develop our hypotheses.  Section 5 discusses our sample, data 
sources, and methodological considerations and details the variables for our longitudinal econometric 
analysis.  Section 6 is dedicated to estimation and results, and Section 7 provides results from post-
estimation robustness checks.  Section 8 discusses our findings together with the case study analysis 






2. Theoretical background: Alliance experience and alliance capabilities  
To explain heterogeneity with respect to firm’s abilities to benefit from alliances, the alliance literature 
resonates strongly with knowledge and capability based theories of the firm (e.g. Kogut and Zander, 
1992, Helfat and Peteraf, 2003).  Here, we adopt a perspective that is informed by both evolutionary 
theory of the firm (Nelson and Winter, 1982) and dynamic approaches to the resource based view 
(RBV) (Helfat et al., 2007, Helfat and Peteraf, 2003).  These approaches take a dynamic view of 
organisational development, emphasising the role of experience and knowledge accumulation in 
supporting improved management and coordination of organisational tasks and activities.  Given their 
dynamic and longitudinal orientation, they are closely aligned with our own analytical approach, 
informing our exploration of the roles of alliance experience accumulation and frequent engagement 
in alliances in organisational learning and enhanced innovation. 
Evolutionary theory argues that by repetitively engaging in organisational tasks, or by gaining 
experience, organisations benefit from efficiency improvements as a result of ‘learning-by-doing’.  As 
firms follow different paths in accumulating and making sense of experience, they become 
heterogeneous in their abilities to carry out similar organisational activities.  Experience assists firms 
in assessing which processes and practices are likely to perform better or to confer improved results, 
by judging on similar situations in the past.  Organisations gradually create routines to efficiently 
coordinate organisational activities and develop capabilities to achieve outcomes important for 
competitive advantage (Dosi et al., 2000, Winter, 2000, 2003, Schilke and Goerzen, 2010, Nelson and 
Winter, 1982).  Experience accumulation is an antecedent to developing capabilities; however, there 
can be a deliberate and conscious process of organisational learning as firms make investments in 
time, resources, training and knowledge to further improve their capabilities (Zollo and Winter, 2002), 
or to improve them through reflecting on newly acquired experience (Helfat and Peteraf, 2003).   
Dynamic approaches to RBV are illuminating on the process of capability development by 
suggesting that there is an evolutionary path to their creation whereby capabilities emerge and 
improve through several developmental stages (Helfat and Peteraf, 2003).  First, there is a ‘capability 
founding’ stage wherein organisations realise the need to develop a capability to meet desirable 
objectives and to orchestrate joint organisational action towards meeting these.  Second, is a 
‘capability development’ stage: here improvements to capabilities arise from a range of factors 
including further experience accumulation, investments in capital, organisational processes and 
learning mechanisms.  Experience accumulation is crucial to both ‘founding’ and ‘development’ stages 
of a capability development.  A third stage, ‘capability maturity’ is also identified: in this phase 
capabilities may be replicated, retrenched, renewed, redeployed or re-combined with other 
capabilities.   
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Even though alliances differ compared to other organisational tasks, in that firms collaborate 
with different partners in agreements with varying content, purpose and governance structure, 
gaining experience in managing alliances can lead to superior coordination, value creation and capture 
in alliances (Kale and Singh, 2007, Heimeriks and Duysters, 2007).  Alliance experience is found to 
enhance the performance of alliances between recurrent partners, as firms use their experience and 
routines developed during their first interactions in managing subsequent collaborations within the 
dyad (Zollo et al., 2002).  Moreover, firms mobilise experience and lessons gained across alliances with 
different partners (Anand and Khanna, 2000), with partner-specific alliance experience making a 
greater contribution to performance compared to general (i.e. non-partner specific) experience 
(Gulati et al., 2009).    
Alliance experience (a firm’s cumulative number of alliances) is an antecedent to both superior 
coordination of alliance tasks (alliance capabilities), and to the efficient management of synergies and 
redundancies across alliances in alliance portfolios (alliance portfolio capabilities) (for a review see 
Wang and Rajagopalan, 2015).  Kale and Singh (2007) were the first to detail how firms proactively 
learn from their alliance experience by externalising, codifying, diffusing and internalising individual 
and group-level alliance know-how.  A stream within the alliance literature explores the link between 
cumulative alliance experience, the development of dedicated alliance management functions and 
other processes and practices connected with upgrading alliance management routines (Kale et al., 
2002, Heimeriks and Duysters, 2007, Kale and Singh, 2007).  Alliance functions reflect alliance 
capabilities and can lead to superior outcomes from alliances.  Alliance experience indirectly affects 
firm performance via such capabilities, indicating that dedicated alliance functions embody and 
absorb the impact of alliance experience, suggesting that firms leverage all the learning gained from 
experience in their alliance management functions (Kale et al., 2002).  Other research suggests that 
alliance experience directly influences both financial (Kale et al., 2002, Anand and Khanna, 2000) and 
non-financial outcomes such as innovation performance (Sampson, 2005), and that this is in addition 
to any impact conferred by dedicated alliance functions, suggesting a complementary relationship 
between the two (Heimericks and Duysters, 2007).  Indeed, systematic alliance practices are improved 
through training, mentoring programmes and external consulting.  Such learning processes aim at 
introducing new alliance management practices and/or at improving existing ones in response to 
dissatisfaction with current performance (Zollo and Winter, 2002).   
The following section revisits existing but still contested hypotheses on the expected impact 
of alliance experience on firm innovation performance.  We also develop our hypothesis on the impact 
of alliance frequency, which from a longitudinal perspective can be better positioned to capture 
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nuancing and conditioning factors that reflect the impact of organisational learning from alliance 
experience on innovation.   
 
3. Alliance experience and firm returns from alliances 
Firms with greater experience can draw from a greater pool of situations about what has 
worked in practice, when making decisions and inferences with respect to the performance of 
organisational practices (Levitt and March, 1988, Argote et al., 1990).  Alliance experience (cumulative 
number of alliances) improves firms’ abilities: to manage and coordinate alliances, to improve 
coordination of inter-organisational relationships and joint tasks, to form efficient arrangements for 
knowledge sharing, to deal effectively with unforeseen contingencies, and to identify ways to 
overcome and resolve inter-partner conflict (Anand and Khanna, 2000, Sampson, 2005, Belderbos et 
al., 2015, Rothaermel and Deeds, 2006).  Due to the link between alliance experience and 
organisational learning, experience is seen as a fundamental antecedent to both alliance and alliance 
portfolio capabilities (Wang and Rajagopalan, 2015, Kale and Singh, 2009, Shukla and Mital, 2018).  
Literature suggests that firms may not be in a position to benefit from learning from experience and 
superior coordination of alliances, when facing power asymmetries and resource dependence in 
alliances.  Conflict is more frequent in such alliances which affects value creation and capture, 
especially for the weak partner as they are at a comparative disadvantage (Diestre and Rajagopalan, 
2012).  Power asymmetries are likely in the bio-pharmaceutical sector, as large pharmaceutical firms 
may be collaborating with small-dedicated biotech firms and due to their longer commitment to 
alliances and historic investments in downstream capabilities may be at a comparative advantage in 
deriving value from alliances (Caner and Tyler, 2013).   
We argue that by gaining greater alliance experience, firms gradually establish more fruitful 
conditions for effective knowledge sharing with their partners, and generate a basis for circumventing 
or resolving alliance conflicts.  Because conflicts are more likely to occur in the bio-pharmaceuticals 
sector we expect that the higher the levels of experience the more likely the firms are to capture value 
from alliances and enhance their likelihood of innovation.   
 
Hypothesis 1: Alliance experience accumulation positively affects a firm’s likelihood of 
innovation 
 
A body of work suggests that efficiency improvements from experience accumulation make a 
gradually diminishing contribution to firm performance.  There are two likely explanations for this.  
First, as firms form more alliances and accumulate greater experience, the contribution of any 
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additional alliance to accumulated learning becomes increasingly reduced.  This has been identified 
irrespective of type of partner and across upstream, downstream and horizontal alliances (Rothaermel 
and Deeds, 2006).  Firms may experience diminishing returns when managing an increasing number 
of alliances due to the increased costs associated with identifying suitable partners, establishing and 
maintaining contracts, difficulties in absorbing knowledge from diverse sources, conflicts due to 
knowledge asymmetries and increased possibilities of knowledge redundancies (Diestre and 
Rajagopalan, 2012, Rothaermel and Deeds, 2006, White and Lui, 2005) 
A second likely explanation is that the value of lessons learned from cumulative experience 
depreciates over time as knowledge becomes increasingly obsolete (e.g. Argote et al., 1990).  Past 
knowledge may depreciate as task requirements change over time.  Further, the value of past lessons 
may dissipate gradually (or suddenly) as a result of employee turnover or a failure to store intelligence 
in organisational routines, or in a way that permits its re-application (Levitt and March, 1988, Dutton 
and Thomas, 1984).  Unless firms make appropriate investments in retaining and leveraging lessons 
learned from their experience, its effects will increasingly dissipate.   
Research in the alliance literature has demonstrated a positive and linear relationship 
between alliance experience and firm-level indicators of financial (Anand and Khanna, 2000) and 
innovation performance (Shan et al., 1994).  Only a slender body of work has explored diminishing 
returns to alliance experience.  Hoang and Rothaermel (2005) find that, whilst alliance experience of 
small firms positively impacts the performance of their joint projects with large firms, the alliance 
experience of large firms makes no significant impact on their joint alliance project performance.  
Benefits stemming from alliance experience differ between small and large firms because they are 
positioned at different levels along the diminishing/concave alliance experience curve.  In related 
research, Sampson (2005), commenting on patenting performance in the telecom equipment 
industry, identifies similarly diminishing returns to cumulative alliance experience, which she 
attributes to a diminishing contribution of distant experience, suggesting that distant alliance 
experience plays less important role than recent experience in efficient management of alliance 
portfolios (Shukla and Mital, 2018).  As a consequence, we derive the following hypothesis: 
 
Hypothesis 2: The effect of cumulative alliance experience on likelihood of innovation exhibits 
diminishing marginal returns: as alliance experience accumulates, its contribution to the 






4. Frequent engagement in alliances as an antecedent to alliance capability 
Deciphering, coding and measuring capabilities is notoriously difficult (Godfrey and Hill, 1995).  
As a result, the alliance literature has, in the main, relied on identifying alliance management practices 
(e.g. alliance functions) as a way of documenting alliance capabilities (Kale et al., 2002, Kale and Singh, 
2007, 2009).  An exception is found in the work of Rothaermel and Deeds (2006).  They explore an 
inverted U-shaped relationship between cumulative alliance experience and new product 
development.  They argue that, as the inflection point of the inverted U-shaped curve corresponds to 
the level of experience beyond which firms start experiencing inefficiencies in alliance management, 
it can reflect the level of their alliance capability.   
The notion that dedicated alliance management functions reflect alliance capabilities has 
being challenged in recent literature.  First, anecdotal evidence suggests that firms establish dedicated 
alliance functions only after engaging in alliances over a protracted period, and after initiating a 
substantial number of such agreements (Kale and Singh, 2009).  As a result such functions cannot 
reflect alliance capabilities, particularly when capabilities are at the initial stages of their development.  
Research indicates that firms – especially those motivated by perceived market signaling requiremets 
-  may establish dedicated alliance functions as a result of mimitisism or isomorphism (Heimeriks, 
2010)1.  Indeed, isolated mechanisms for institutionalising learning (e.g. dedicated alliance functions) 
from cumulative alliance experience may prove to be less effective compared to mechanisms designed 
to integrate and embed alliance knowledge throughout the organisation (Heimeriks et al., 2015). 
Despite some tentative and tangential work, explorations with respect to the underlying 
factors that lead firms to become aware of the need to leverage their alliance experience in developing 
a capability, and to invest efforts and resources in processes for deliberate learning from alliances are 
sparse in extant literature (see Wang and Rajagopalan, 2015).  We contend that the first instances of 
frequent engagement in alliances can form such underlying factors and we turn to evolutionary theory 
and dynamic RBV to assist in elaborating our argument.  Specifically, we suggest that frequent 
engagement in alliances may compel firms to found an alliance capability development lifecycle, as 
they both protract the period of engagement in alliances, and engage more substantially in this activity 
(Helfat and Peteraf, 2003).   By engaging in alliances frequently, firms expand, augment and renew 
their stock of cumulative alliance experience.  Frequent engagement in alliances induces firms to 
invest in developing higher order routines and practises to initiate purposeful and directed 
                                                     
1 Heimericks (2010) distinguishes between institutionalising mechanisms for alliance management on the one 
hand (i.e., those that codify alliance learning and standardise it in routine approaches), and integrating 




organisational learning.  Developing processes for alliance management and practices for their further 
improvement requires managerial commitment, commitment that is highly demanding in terms of 
time and employee resources (Winter, 2003, Dosi et al., 2000, Winter, 2000).  As a result, firms need 
to justify the allocation of resources to building dedicated routines for alliance management: frequent 
task reoccurrence can trigger and motivate firms to deploy resources in such a direction.  It can also 
justify such investments to external stakeholders, building internal support and commitment to the 
purpose.  
Sparse empirical literature explores the role of frequent engagement in alliances in developing 
alliance capabilities (see Wang and Rajagopalan, 2015 for a review).  There is a particular dearth of 
longitudinal studies in this field (Draulans et al., 2003, Rothaermel and Deeds, 2006).  Research on CIS 
longitudinal Spanish data indicates that persistent and not sporadic collaboration exhibits a systematic 
positive relationship with firm innovativeness, which runs parallel to our argument (Belderbos et al., 
2015).  Moreover, firms that renew and expand their collaborations and alliances over time become 
more embedded in a network and experience higher growth over time (Powell et al., 2005).  At the 
cross-sectional level, there is only limited research that links larger alliance portfolios to the 
development of alliance capability (as this is reflected in alliance management practices).  Larger 
alliance portfolios are associated with the use of enhanced alliance management practices and 
processes, with the latter being linked to improved firm performance (Heimericks et al., 2009).  Our 
longitudinal approach, capturing the tendencies of firms to engage in alliances more frequently over 
time, complements such accounts which are based on the role of stock measures of alliance 
experience in firm performance (Kale et al., 2002; Heimeriks and Duysters, 2007, Kale and Singh, 
2007).  Therefore we propose that firms that engage in alliances frequently are more likely to innovate 
compared to those firms that (a) engage in alliances irregularly or sporadically, or that (b) retain a 
static engagement and a stagnating alliance portfolio over time.   
 
Hypotheses 3: Frequent engagement in alliances and the ensuing expanding alliance portfolios 
positively affect firm likelihood of firm innovation over time 
 
 
5. Sample and methods 
5.1 Sample 
We test our hypotheses on a panel dataset observing the population of firms in the UK bio-
pharma sector (110 firms in 2003) during the period 1991 to 2001.  The empirical exploration in this 
paper relies fundamentally on econometric analysis.  However, secondarily the paper employs a case 
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analysis to shed further light on - and nuance - some of its arguments.  To identify our sample, we 
used two editions of the UK biotechnology directory (Coombs and Alston, 2000, 2002).  The directory 
lists all firms in the sector that undertake research using biotechnologies.  It provides a more 
comprehensive account of the firms in the UK bio-pharma sector than that available via the use of SIC 
classifications, as biotechnologies are used by firms from a range of industries in the life sciences as 
broadly described (Walsh, 2004).  To form our working sample, we used the ‘Who Owns Who’ 
directory to identify all firms that were active in 2003.  Out of that list, we identified 110 firms that 
publish accounts in FAME2. 
For the sample of 110 firms, we collected data on alliances from ReCap.com and BioScan, the 
two most popular sources of alliance data in empirical research on this sector (e.g. Deeds and Hill, 
1996, Schilling, 2009).  The databases report alliances established in the bio-pharmaceutical sector for 
innovation purposes, including R&D alliances, research alliances, and alliances for technology licensing 
and product development3.  
Innovation is crucial to firm survival and prosperity in the bio-pharmaceutical sector and 
patents are perceived as an appropriate proxy for innovations due to the science-based nature of the 
sector (e.g. Pavitt, 1984).  Moreover, patents are an appropriate indicator to capture firm-level returns 
from innovation alliances (Demirkan, 2018, Shan et al., 1994, Sampson, 2005).  We collected data on 
patents granted to the 110 firms in our sample between 1991 and 2001 by the UKPTO through the 
publicly-available database Esp@cenet.   Via deployment of boolean searches, it was possible to 
assemble a comprehensive list by matching both the name and the address of firms in our sample with 
those of the patent assignees (Arora et al., 2011).  For firms in our sample that belong to MNEs with 
non-UK based HQs, we examined information on inventor location, and allocated any patents assigned 
to the MNE HQ with UK-based inventors to the UK-based subsidiary in our sample.  Since our research 
focuses on UK-based firms, the UKPTO is perceived to be an appropriate source for the collection of 
patent data.  Filing patent applications at national patent offices is less costly (in terms of application 
and renewal fees) and less time consuming when compared with international patent applications.  
As international applications also involve costs of unfamiliar IP regulations and legal frameworks, 
many firms - at least those with constrained resources - are more likely to patent at national patent 
offices than internationally (Archambault, 2002).  Finally, information on firm accounts was obtained 
                                                     
2 FAME provides financial information relating to all UK listed companies. 
3 Both databases are literature based, a factor that raises some concerns with respect to possible under-
representation of alliances of smaller value or those involving smaller firms.  Confidence is bolstered however, 
by recent research that demonstrates the results of empirical studies to be independent of the use of 
particular alliance databases (Schilling, 2009). 
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from FAME, and information on investments in R&D was gathered from Thomson’s Analytics and the 
UK DTI’s R&D Scoreboard.   
 
5.2 Methods 
Patents take positive integer values, making count dependent variable models, such as the 
Poisson and Negative Binomial, appropriate (Greene, 2003).  Instead of count dependent variable 
models, we employ discrete dependent variable models as they permit the capture of factors that 
alter firm abilities enabling them to perform over a threshold level: successful filing of a patent (Long, 
1997).  This is better aligned to the core aim of this work, which is to explore whether frequent alliance 
engagement is linked to organisational learning in alliance management (and alliance capabilities), 
reflected in firms exhibiting over threshold performance  (Hoang and Rothaermel, 2005).   
Due to the longitudinal dimension of panels, we can explore factors that affect firms’ changing 
abilities to innovate over time (fixed effects specification), as well as factors that can explain cross-
firm variation in innovation abilities (random effects specification).  The former, dynamic 
consideration of panels is of particular interest in this paper, as explained above. The fixed effects 
specification has a further appeal as its estimates are not based on the assumption of strict exogeneity 
of the independent variables (Greene, 2003, Baltagi, 1995), which is desirable, as decisions to form 
alliances may not be independent of past innovation performance (Colombo and Garrone, 1996, 
Gkypali et al., 2017).   
To explore further the nuanced factors underlying the development of alliance capabilities, 
we report on the findings of an in-depth case analysis that explores the link between frequency of 
engagement in alliances, and the development of practices and processes to manage alliances, an 
indication of alliance capabilities (Schreiner et al., 2009, Kale and Singh, 2007); this is a secondary 
analysis providing an illuminating complement.  The case focuses on a UK bio-pharmaceutical firm 
that intensified its engagement in alliances particularly after the early 1990s when it started to invest 
in biotechnology R&D.  Interviews were conducted in 2005 as the firm was forming a dedicated 
alliance function and entailed detailed reflection on the factors that underpin the creation of 
processes established to improve efficiency in alliance management.  The processes identified were 
matched with those identified in existing literature on alliance capabilities (Kale et al., 2002, Kale and 
Singh, 2007, 2009, Heimericks and Duysters, 2007).  The case is based on interviews with directors of 
alliances and intellectual property, with a long working experience with the case firm and focused on 
alliances that involve cooperation in research and that have led to patents. All materials and 





Patents (dependent variable) 
To test our hypotheses we create a dummy variable that is equal to 1 for each firm that is 
granted a patent at year t (and equal to zero otherwise).  We use a patent dummy variable as we aim 
at capturing the impact of alliance experience in enabling firms to perform over a threshold, i.e. to 
innovate.  To track the firm’s innovation activities over time, we use patent filing dates.  Filing dates 
have certain advantages over publication dates: first, they better reflect the originating time of 
innovations; and, second, they are not influenced by regulatory changes or fluctuations in resource 
availability in patent offices over time, as these can delay publication dates (e.g. Jaffe, 1986).  Patents 
are widely used to capture firm returns from innovation alliances (Sampson, 2005, 2007, Shan et al., 
1994, Demirkan, 2018).   
 
Alliance experience 
Research has explored the role of alliance experience in improving financial returns of firms 
from alliances (Kale et al., 2002), alliance project success (Hoang and Rothaermel, 2005), returns to 
firm innovation performance (Sampson, 2005, 2007, Belderbos et al., 2015, Di Guardo and Harrigan, 
2016) and number of products under development (Deeds and Hill, 1996, Rothaermel and Deeds, 
2006).  Studies have operationalised alliance experience as a stock variable reflected either by the 
cumulative number of alliances formed throughout a firm’s history (Kale and Singh, 2007, Hoang and 
Rothaermel, 2005, Kale et al., 2002, Rothaermel and Deeds, 2006), or by the cumulative number of 
years of experience in engaging in alliances (Rothaermel and Deeds 2006).  Only a handful of these 
studies consider diminishing (Sampson, 2005) or non-linear (Rothaermel and Deeds, 2006) 
relationships between alliance experience and firm returns from alliances and most studies base their 
estimates on cross-sectional data (an exception is Kale et al., 2002). 
Following existing literature, we operationalise alliance experience at each year t as the 
cumulative number of alliances throughout a firm’s history.  To aid interpretation of results, and 
following recent contributions (Lavie et al., 2011) we use one year lagged values of the above variable 
to more accurately capture the effect of cumulative alliance experience.  Our variable is left-censored 
to 1991, the start year for our sampling.  This is experienced elsewhere in alliance literature (e.g. Kale 
and Singh, 2007).  Also, because in our study 87% of total alliances from 1979 and 2001 fall within the 
1991-2001 period, left censoring is not introducing considerable bias.  As is customary in the literature 
(Sampson, 2005), we use the natural logarithmic transformation of cumulative alliance experience to 
test for diminishing returns (hypothesis 2).  As a robustness check, we test for a concave relationship 
(inverted U-shaped) by using both the linear and quadratic values of the cumulative number of 
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alliances: again, this approach follows relevant literature (e.g. Deeds and Hill, 1996, Rothaermel and 
Deeds, 2006)4.   
 
Frequent engagement in alliances and expanding alliance portfolios 
To explore the effects of frequent engagement in alliances on firm abilities to innovate, we 
measure the total number of on-going alliances that a firm manages simultaneously at any point in 
time.  As alliances last for several years, this requires information on alliance duration which is not 
available via the alliance data sources consulted in this study (RECap.com and BioScan).  As lack of 
information on alliance duration has also been encountered in other work, we follow established 
tradition and rely on estimates of the average duration of alliances, i.e., five years (Kogut, 1988, Di 
Guardo and Harrigan, 2016).  Therefore, we operationalise frequent engagement in alliances by 
calculating the number of alliances a firm manages at any given point in time by considering that 
alliances last on average for five years.  Increases in this variable reflect the tendency of firms to 
engage more frequently in alliances over time, and on average, to initiate more alliances than they 
terminate, managing potentially an expanding portfolio of on-going alliances.  As the use of a blanket 
measure for alliance duration might be considered simplistic, we cross-validated this information with 
alliance managers in the sector, and it was considered an acceptable approximation for the duration 
of the majority of alliances.  We also performed robustness checks by using different estimates for 
alliance duration as detailed in our analysis.  
 
Control variables 
For parsimonious empirical models, we use the most appropriate control variables that have been 
employed in the literature on alliances and innovation.  First, we account for the effects of well-
established indicators of firm innovation, such as investments in R&D and firm size (Griliches, 1990) 
as they can influence firm abilities to innovate.  We used a measure of R&D intensity that captures the 
amount of R&D expenditure per employee.  Firm size is captured by annual turnover and we include 
a natural logarithm to overcome the possible problem of skewed distributions.  Second, and following 
relevant research (Zollo et al., 2002), we account for differences in the content of alliances, as it 
influences innovation opportunities in alliances and affects firm performance (e.g. Anand and Khanna, 
2000).  Therefore, we include a dummy that takes the value of one when the focal firm establishes an 
                                                     




alliance that involves R&D, and the value of zero for each year that a focal firm establishes alliances 
that do not involve R&D.  
 
6. Estimation and results 
Table 1 presents descriptive statistics and bivariate correlations.   
----------------------------------------- 
Insert Table 1 about here 
----------------------------------------- 
 
The panel is unbalanced, as a result of either missing information or the inclusion of less-
mature dedicated biotechnology firms (i.e. a third of firms in the sample were established after 1995).  
The unbalanced dataset includes firms observed for a maximum period of 10 years and others for as 
little as 4 years.  On average, firms are observed for approximately 7 years (the range is from 6.6 to 
7.4 years across the three estimated models) and form 8.28 alliances between 1991 and 2001.  
We estimated both the Fixed and Random Effects specifications (FE and RE respectively) of 
the Logit model for panel data for all three models (Greene, 2003, Baltagi, 1995)5.  Results are 
obtained in STATA© 11.  The Rho parameter is significant across all three models, indicating significant 
cross-firm heterogeneity.  As the Hausman (1978) specification test has limited discerning power in 
discrete dependent variable models, we assess the relative merits of the two specifications on a 
conceptual basis and for reasons discussed in the methods section we present Logit FE estimates.  
Moreover, the residuals of the FE specification are corrected for potential heteroscedasticity (White, 




Insert Table 2 about here 
----------------------------------------- 
Based on model Chi2 statistics in Table 2, all three models are significant at 5% levels and 
above.  This suggests that our variables have a significant interpretative power with respect to the 
likelihood of firm innovation.  We find support for all hypotheses.  In Model 1, the cumulative number 
of alliances positively affects firm’s likelihood of innovation over time, but levels of significance are 
                                                     
5 The Probit model provides an alternative specification to Logit.  However, both models provide the same 
results in terms of significance levels (Long, 1997).   
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low (10%).  Our results are consistent with studies showing a positive relationship between cumulative 
alliance experience and firm innovation, but at low significance levels (Hagedoorn and Schakenraad, 
1994, Shan et al., 1994).   
The FE estimates of Model 2 provide support for diminishing returns to firm innovation from 
cumulative alliance experience, with the corresponding variable being positive and highly significant.  
The results of Model 2 are consistent with findings testing similar hypotheses in cross-sectional 
settings in the US bio-pharmaceutical and the telecom equipment industries (Hoang and Rothaermel, 
2005, Sampson, 2005).  Our results are robust to alternative operationalisations, as reflected by 
exploring concave relationships (inverted U-shaped), via use of both linear and quadratic values of 
cumulative alliance experience, with estimates (both FE and RE) confirming non-linear diminishing 
returns to likelihood of firm innovation.  To unpack the extent of diminishing returns we estimate the 
inflection point based on estimates of the curvilinear relationship; this is equal to 127.515 points of 
cumulative experience, which corresponds to firms managing 18 alliances annually (average length of 
time per firm in the panel is 7 years).  Our results imply that at such a level of annual alliance activity, 
firms will accrue no additional benefits from gaining more experience in managing alliances.  It should 
be noted that in our sample the average number of new alliances formed every year is 8.28, which 
suggests that the majority of firms in our sample are below the optimal level of alliance engagement.  
The concluding section discusses the implications of this.  
Model 3 provides support for our third hypothesis.  The coefficient of the core independent 
variable is positive and significant (it marginally fails to pass the highest 1% level of significance).  
Model 3 suggests that firms that establish alliances frequently and that continuously manage an 
expanding portfolio can enjoy improved likelihood of innovation.  This provides fresh insights as, to 
date, there has been a scarcity of longitudinal studies in the literature (see Draulans et al., 2003, 
Rothaermel and Deeds, 2006).  As a test of robustness, we estimated Model 3 by using 4 and 6 years 
as the average duration for alliances.  The results remained robust to different operationalisations.  
Among the control variables, firm size is positively and significantly associated with firm’s likelihood 
of innovation in Models 1 and 3.  Investments in R&D per number of employees is negatively 
associated with likelihood of firm innovation but only in Model 2.  Alliance content is insignificant 
across all three models. 
Finally, all three model estimates are robust to different measures of the control variables.  For 
example, all models lead to the same outcomes in terms of significance when controls are collapsed 
to dichotomous variables indicating above and below average firm size and intensity of investments 
in R&D per number of employees.  A further robustness check is undertaken to examine whether our 
results are sensitive to the statistical assumptions of the distribution followed by the error term in the 
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Logit and Probit specifications.  The Probit model only provides RE estimates for panel data (STATA© 
11) and these further confirm our results.  Moreover, we estimate our model specifications with the 
Negative Binomial model to explore differences between our dependent variable and a count variable 
capturing innovation performance with the number of patents.  Both FE and RE estimates confirm our 
hypotheses.  
 
7. Tests of Robustness6 
The results suggest that there are diminishing returns to cumulative alliance experience.  This can 
signal that ageing experience contributes less to current outcomes and that recent experience may 
have a higher contribution (Shukla and Mital, 2018, Sampson, 2005).  Following Sampson (2005) we 
explore the contributions of recent and past alliance experience.  We develop a set of variables 
capturing alliance experience between 1 and 6 years prior to our year of observation.  So, for example, 
in 2001 alliance experience of 1 year corresponds to the number of alliances initiated in 2000 and 
alliance experience of 2 years corresponds to those initiated in 1999 and so on.  None of these 
variables appear to be significant, with the exception of alliance experience of 4 years prior to the year 
of observation, which appears with a negative and significant sign.  Therefore, the diminishing returns 
to cumulative alliance experience identified in our paper cannot be attributed to decreasing 
contributions of distant experience.  Our results most likely reflect that firms, by just forming more 
alliances and learning from experience how to improve alliance management and coordination, 
cannot experience improved efficiency ad infinitum.   
With regards to Hypothesis 3 we undertake further estimations to isolate the impact of  
frequent engagement in alliances from that of portfolio size.  We break down the variable testing 
Hypothesis 3 into two components.  First, capturing changes in the frequency of forming alliances over 
time, we construct a variable reflecting a decreasing, static and increasing trend in alliance portfolios 
(the variable takes the values of: -1, 0 and 1 respectively and refers to comparisons between the 
current and the previous year).  Second, we include a variable to capture the number of new alliances 
formed within every year (one year lagged values are used in the models).  Our results show that the 
trend variable has a negative sign while the annual figures of newly formed alliances appear with a 
positive and significant sign (both for the Logit and the Negative Binomial models and the FE and RE 
specifications).  It is worth noting that when the values of the trend variable are lagged by one year, 
their impact becomes insignificant (that is, they retain a negative sign).  This means that only the 
                                                     
6 Results are available upon request. 
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contemporaneous impact of alliance frequency on innovation is negative, implying that when firms 
expand their alliance portfolio there is an immediate adverse effect.  This may result from immediate 
strains on their resources and cognitive abilities, which however, cease to have an adverse effect 
within a year’s time. The results remain the same when the trend variable is substituted with a dummy 
variable capturing only increases in the frequency of forming alliances between current values and 
those of the previous year.   
Finally, we isolate partner-specific alliance experience from general (i.e. non-partner specific) 
experience to further explore the importance of alliance management learning within partner dyads 
and in alliance portfolios.  None of these variables has a significant effect, suggesting that the 
separation lacks interpretative power.  
  8. Discussion 
The paper contributes to the literature on the role of alliances in innovation and alliance 
capabilities by using a longitudinal analysis which enables capture of the impact of organisational 
learning in managing and coordinating alliances on innovation.  As it is difficult to capture learning, 
the paper uses a longitudinal approach to capture dynamic changes within firms and it observes 
learning through its impact on outcome variables such as innovation.  The paper adds to a slender 
body of work exploring antecedents to firm level alliance capabilities and their impact on enhancing 
firm’s abilities to innovate (for a review see Wang and Rajapolagan, 2015).   
First, we find that the impact of learning from gaining greater alliance experience in 
coordinating alliances and portfolios on firm innovation is positive but of weak significance.  This is an 
important finding, as alliances in the bio-pharmaceutical sector can be characterised by power 
asymmetries and unbalanced resource dependence between partners, which are likely to create 
conflicts affecting the creation and appropriation of alliance value (Diestre and Rajagopalan, 2012, 
Caner and Tyler, 2013).  The period of our study forms the first window of exploitation of 
biotechnologies via alliances which potentially creates disincentives to collaborating firms to behave 
opportunistically, as joining forces during this close to pre-competitive stage could be more beneficial 
than not (Powell et al., 2005).  
Second, our analysis proceeds by exploring the factors that affect learning in managing and 
coordinating alliances in this sector.  The first arm to this exploration sheds light on the role of 
cumulative-historic experience in enhancing innovation performance, while the second arm focuses 
on the role of such experience as an antecedent to the creation of capabilities to manage interactions 
with alliance partners and to create synergies and minimise redundancies in alliance portfolios.  In 
that endeavour, we first confirm diminishing returns to the benefits that can be accrued by gaining 
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alliance experience for more effective management of alliances and capturing innovation returns.  This 
supports a thin body of research which suggests that learning from gaining experience cannot confer 
benefits ad infinitum (e.g. Rothaermel and Deeds, 2006; Sampson, 2005).  Our in-depth exploration 
shows that this cannot be attributed to diminishing contributions of ageing experience as identified in 
other work (Sampson, 2005, Shukla and Mital, 2018).  It could be attributed to failure of firms to 
capture learning in a systematic way, or to costs associated with identifying more partners, 
establishing more agreements, and coordinating increased diversity (White and Lui, 2005, Rothaermel 
and Deeds, 2006).  
Our last set of findings show that engaging in alliances more frequently over time, with firms 
managing an expanding portfolio, by forming more alliances than they terminate, enhances firms’ 
likelihood of innovation.  Our longitudinal approach is consistent with other work showing that 
persistence in collaboration has a positive impact on firm innovation as opposed to sporadic 
collaboration (Belderbos et al., 2015).  Longitudinal explorations are currently almost absent in 
alliance literature, and their potential contribution has been particularly welcomed (Draulans et al., 
2003, Rothaermel and Deeds, 2006), specifically as they might shed further light on the type of 
changes that can occur within firms, in particular, with respect to the dynamics of learning on alliance 
management and how it enhances innovation potential.  Contributions within evolutionary theory 
(Winter, 2000, 2003) argue that frequent engagement in organisational tasks is linked to capability 
development, while the dynamic resource-based view (Helfat and Peteraf, 2003) argues that 
capabilities develop through several stages: experience accumulation compels firms to recognise the 
need to establish a capability, and this initiates a process of systematic learning and alliance 
management.  Our results clearly pertain to this literature and specifically on how alliance experience 
forms an antecedent to alliance and alliance portfolio capabilities (Wang and Rajagopalan, 2015).  To 
explore, in a situated and more granular fashion, whether frequent engagement in alliances and a 
dynamically expanding alliance portfolio contribute to the development of alliance capabilities, we 
conducted a detailed case analysis as a complement to our econometric analysis.  The case analysis 
explores the link between an increasing engagement in alliances and the development of novel or 
changed practices and processes for alliance management, i.e., those factors that normally sit within 
the “black-box” of alliance capability studies (Anand and Khanna, 2000, Heimeriks and Duysters, 2007, 
Kale and Singh, 2007).   
The case analysis clearly reveals such a relationship. First, it shows that alliance management 
practices and routines are established after alliances become an integral part of firm R&D and 
innovation strategy and firms intensify and commit to alliance activity.  As the Alliance Director 
interviewed for our study stated: “…we have standardised approaches for contractual compliance 
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[with respect to alliances]… it’s inconceivable to me that one wouldn’t have, and yet five years ago we 
didn’t… You’ve got one deal and you do it however you do it which largely depends on who you employ 
and who it’s [the alliance] with… I am not sure how many deals you need to have before you get 
yourself a standardised process but it’s probably substantially more than ten or twenty…”.7  Second, 
several of the practices identified in the extant literature that are used to institutionalise and diffuse 
alliance management learning (namely, employment of alliance professionals, use of alliance metrics, 
creation of databases to solicit potential alliance partners, and establishment of processes to monitor 
alliance performance) are deployed by the case firm (Heimericks and Duysters, 2007, Kale and Singh, 
2007).  Ten years after intensifying alliance engagement, it developed a dedicated alliance 
management function to coordinate alliance activity and engage in monitoring and improving existing 
alliance management practices.   
The case analysis illustrates the links between frequent engagement in alliances and the ensuing 
expanding the alliance portfolio, with the motivation to invest resources in developing firm-specific 
capabilities for alliance management.  It also reflects the time required to recognise that alliance 
management can be improved via the development of specific and specialist processes for the 
governance of cross-partner interaction (a finding that resonates strongly with existing literature (Kale 
and Singh, 2009)).  In addition, the case reflects the requirement for firms to continuously review and 
develop their capabilities in order to confront new challenges and intensified competition.  Indeed, 
the case analysis, combined with the findings of our econometric exploration, suggest that renewing 
alliance experience and committing to forming more alliances over time are crucial in enabling firms 
to create and capture value in alliances.  
9. Implications for management theory and practice  
Our research contributes to the literature on the antecedents of alliance and alliance portfolio 
capabilities and on the conditions that shape superior firm outcomes from alliances, such as 
innovation.  It suggests a need to delve into the antecedents to alliance capabilities, a thin body of 
research and to identify nascent factors that provide potential foundations for alliance capability 
development (Helfat and Peteraf, 2003), shifting attention away from the role played by alliance 
management practices (such as dedicated alliance functions) that have dominated existing research.  
This is particularly important as firms may establish such practices during the advanced stages of the 
alliance capability development process (Kale and Singh, 2009), and as such they may not 
appropriately reflect the foundational stages of alliance capability development.  Here we echo calls 
to delve deeper in understanding alliance management capabilities and the antecedents to alliance 
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portfolio capabilities (Wang and Rajagopalan, 2015), especially in the context of alliances involving a 
higher learning potential (Heimeriks, 2010).  Moreover, recent research shows that codification of 
alliance learning and systematic approaches to alliance management contribute to efficient partner 
selection and alliance termination, but may restrict flexibility and adaptability which are important for 
efficient management during the course of the alliance (Heimeriks et al., 2015, Wang and Rajagopalan, 
2015). 
Our research has several implications for managerial practice and policy.  First, we find that 
there are diminishing returns to benefits in terms of enhanced innovation accruing from gaining 
greater alliance experience.  Specifically firms reach a plateu at 18 alliances in annual terms, suggesting 
that on average this is the optimal level of alliance engagement for enhancing firm likelihood of 
innovation.  This has implications for managing alliance portfolio size for innovation efficiency (e.g. 
Hoffmann, 2007, Demirkan, 2018).   On average firms in our sample are below the optimal level of 
alliance engagement (forming 8 alliances annually).  This suggests that innovation likelihood can be 
marginally enhanced by expanding alliance engagement.  This is in line with findings of other research 
(Rothaermel and Deeds, 2006; Sampson, 2005; Hewitt-Dundas and Roper, 2018) which in the context 
of micro-businesses for example, shows that sub-optimal engagement can be attributed to reluctance 
of firms to cooperate due to fear of trustworthiness and lack of knowledge on benefits of collaboration 
and partner capabilities (Hewitt-Dundas and Roper, 2018).  This emphasises our findings with respect 
to the need to faciliate a culture of systematic management of alliances.  It also supports research 
suggesting the need for policy interventions, for example in the form of intermediaries, which can 
support and encourage firms to establish collaborations and manage openness (Howells, 2006).  This 
is not only due to the benefits of collaboration to firm innovation but also due to the positive 
externalities from openess, suggesting broader economic and societal benefits (Roper et al., 2013).   
At the firm level, our results suggest that it is important for firms to replenish their alliance 
portfolios and to gradually form more alliances than they terminate over time if they wish to enhance 
their innovation likelihood.  In the bio-pharmaceuticals sector where there is high rate of alliance 
formation, it is important for firm competitiveness and future growth that they renew and expand 
their networks (Powell et al., 2005).  This is linked to firms becoming more aware of the need to make 
alliance management learning more systematic.  Firms should use such systematic practices in a 
discretionary manner and should also consider altering and upgrading such practices to respond to 
the challenges and demands of new alliances.  Although our results are specific in terms of sector and 
period, they derive from the examination of a paradigmatic period in the development of new 
technologies, and address the implications of changing innovation processes in an established 
industry.  As such, they provide useful insights that assist understanding of trajectories and dynamics 
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in industries with similarities to biotech, for example, nanotechnology (e.g. Rothaermel and Thursby, 
2007).   Our aspiration is that our research will provide some re-focusing and clarity in an established 
field of study.  We acknowledge that analysis of further sectors and periods will nuance our 
understanding of both the role of gaining experience in improving firm alliance management and in 
developing alliance capabilities, and hope that the ideas and methods explored above will assist in this 
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